{"id":1156,"date":"2026-08-21T08:00:31","date_gmt":"2026-08-21T11:00:31","guid":{"rendered":"https:\/\/www.vitapharmaconsulting.com\/en\/?post_type=noticias&#038;p=1156"},"modified":"2026-08-20T18:54:51","modified_gmt":"2026-08-20T21:54:51","slug":"anvisa-releases-priority-queues-for-gmp","status":"publish","type":"noticias","link":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/21\/anvisa-releases-priority-queues-for-gmp\/","title":{"rendered":"ANVISA releases priority queues for GMP certification applications"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Brazil&#8217;s Health Regulatory Agency (ANVISA) has begun publishing queues of Good Manufacturing Practice (GMP) Certification applications that received priority for analysis and inspection scheduling, under Resolution RDC No. 1,032, of July 8, 2026, which amended <\/span><a href=\"https:\/\/anvisalegis.datalegis.net\/action\/ActionDatalegis.php?acao=abrirTextoAto&amp;tipo=RDC&amp;numeroAto=00000497&amp;seqAto=000&amp;valorAno=2021&amp;orgao=RDC\/DC\/ANVISA\/MS&amp;codTipo=&amp;desItem=&amp;desItemFim=&amp;cod_menu=1696&amp;cod_modulo=134&amp;pesquisa=true\"><span style=\"font-weight: 400;\">Resolution RDC No. 497\/2021<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><!--more--><\/p>\n<h2>How the prioritization works<\/h2>\n<p><span style=\"font-weight: 400;\">The published lists present, in accordance with the criteria defined in Art. 5 of RDC No. 497\/2021 (as amended by RDC No. 1,032\/2026), the GMP applications with prioritized analysis and inspection scheduling. This allows the regulated sector to monitor the processing order of the included dossiers and plan their activities based on this schedule.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The queues will be updated periodically, reflecting the progress of ANVISA&#8217;s analyses and scheduled inspections. Companies can also contribute to these updates by reporting the marketing authorization process number and the prioritized certification application number through ANVISA&#8217;s <\/span><a href=\"https:\/\/forms.cloud.microsoft\/pages\/responsepage.aspx?id=P_J6tvPDNU2Ax7cIX17dgS2zMU8Va-hBuJAEuN7d0zxUREFDNlJFOEhSRU5RM04xM0w3RTJNQ0VLNC4u&amp;route=shorturl\"><span style=\"font-weight: 400;\">CBPF\u2013Registration Process Linkage Form<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<h2>Impact for the pharmaceutical industry<\/h2>\n<p><span style=\"font-weight: 400;\">According to the Agency, publishing the queues is meant to support administrative efficiency and the optimization of public resources, giving companies greater predictability on the progress of their applications and strengthening risk-based management in GMP certification.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The updated queue of prioritized GMP applications linked to registration applications is available <\/span><a href=\"https:\/\/www.gov.br\/anvisa\/pt-br\/centraisdeconteudo\/publicacoes\/certificacao-e-fiscalizacao\/peticoes-priorizadas\/priorizacoes-14-08-2026.pdf\/@@display-file\/file\"><span style=\"font-weight: 400;\">here<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n","protected":false},"author":3,"featured_media":1157,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"_links_to":"","_links_to_target":""},"categorias":[22],"class_list":["post-1156","noticias","type-noticias","status-publish","has-post-thumbnail","hentry","categorias-brasil-anvisa"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ANVISA releases priority queues for GMP certification applications<\/title>\n<meta name=\"description\" content=\"Brazil&#039;s Health Regulatory Agency (ANVISA) has begun publishing queues of Good Manufacturing Practice (GMP) Certification applications that received priority for analysis and inspection scheduling, under Resolution RDC No. 1,032, of July 8, 2026, which amended Resolution RDC No. 497\/2021.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/21\/anvisa-releases-priority-queues-for-gmp\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANVISA releases priority queues for GMP certification applications\" \/>\n<meta property=\"og:description\" content=\"Brazil&#039;s Health Regulatory Agency (ANVISA) has begun publishing queues of Good Manufacturing Practice (GMP) Certification applications that received priority for analysis and inspection scheduling, under Resolution RDC No. 1,032, of July 8, 2026, which amended Resolution RDC No. 497\/2021.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/21\/anvisa-releases-priority-queues-for-gmp\/\" \/>\n<meta property=\"og:site_name\" content=\"Vita\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2026\/08\/ANVISA-releases-priority-queues-for-GMP-certification-applications.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1800\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/news\\\/2026\\\/08\\\/21\\\/anvisa-releases-priority-queues-for-gmp\\\/\",\"url\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/news\\\/2026\\\/08\\\/21\\\/anvisa-releases-priority-queues-for-gmp\\\/\",\"name\":\"ANVISA releases priority queues for GMP certification applications\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/news\\\/2026\\\/08\\\/21\\\/anvisa-releases-priority-queues-for-gmp\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/news\\\/2026\\\/08\\\/21\\\/anvisa-releases-priority-queues-for-gmp\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/ANVISA-releases-priority-queues-for-GMP-certification-applications.jpg\",\"datePublished\":\"2026-08-21T11:00:31+00:00\",\"description\":\"Brazil's Health Regulatory Agency (ANVISA) has begun publishing queues of Good Manufacturing Practice (GMP) Certification applications that received priority for analysis and inspection scheduling, under Resolution RDC No. 1,032, of July 8, 2026, which amended Resolution RDC No. 497\\\/2021.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/news\\\/2026\\\/08\\\/21\\\/anvisa-releases-priority-queues-for-gmp\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/news\\\/2026\\\/08\\\/21\\\/anvisa-releases-priority-queues-for-gmp\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/news\\\/2026\\\/08\\\/21\\\/anvisa-releases-priority-queues-for-gmp\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/ANVISA-releases-priority-queues-for-GMP-certification-applications.jpg\",\"contentUrl\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/ANVISA-releases-priority-queues-for-GMP-certification-applications.jpg\",\"width\":1800,\"height\":900,\"caption\":\"ANVISA releases priority queues for GMP certification applications\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/news\\\/2026\\\/08\\\/21\\\/anvisa-releases-priority-queues-for-gmp\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Not\u00edcias\",\"item\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ANVISA releases priority queues for GMP certification applications\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/\",\"name\":\"Vita\",\"description\":\"Regulatory affairs &amp; consulting\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.vitapharmaconsulting.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ANVISA releases priority queues for GMP certification applications","description":"Brazil's Health Regulatory Agency (ANVISA) has begun publishing queues of Good Manufacturing Practice (GMP) Certification applications that received priority for analysis and inspection scheduling, under Resolution RDC No. 1,032, of July 8, 2026, which amended Resolution RDC No. 497\/2021.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/21\/anvisa-releases-priority-queues-for-gmp\/","og_locale":"pt_BR","og_type":"article","og_title":"ANVISA releases priority queues for GMP certification applications","og_description":"Brazil's Health Regulatory Agency (ANVISA) has begun publishing queues of Good Manufacturing Practice (GMP) Certification applications that received priority for analysis and inspection scheduling, under Resolution RDC No. 1,032, of July 8, 2026, which amended Resolution RDC No. 497\/2021.","og_url":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/21\/anvisa-releases-priority-queues-for-gmp\/","og_site_name":"Vita","og_image":[{"width":1800,"height":900,"url":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2026\/08\/ANVISA-releases-priority-queues-for-GMP-certification-applications.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/21\/anvisa-releases-priority-queues-for-gmp\/","url":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/21\/anvisa-releases-priority-queues-for-gmp\/","name":"ANVISA releases priority queues for GMP certification applications","isPartOf":{"@id":"https:\/\/www.vitapharmaconsulting.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/21\/anvisa-releases-priority-queues-for-gmp\/#primaryimage"},"image":{"@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/21\/anvisa-releases-priority-queues-for-gmp\/#primaryimage"},"thumbnailUrl":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2026\/08\/ANVISA-releases-priority-queues-for-GMP-certification-applications.jpg","datePublished":"2026-08-21T11:00:31+00:00","description":"Brazil's Health Regulatory Agency (ANVISA) has begun publishing queues of Good Manufacturing Practice (GMP) Certification applications that received priority for analysis and inspection scheduling, under Resolution RDC No. 1,032, of July 8, 2026, which amended Resolution RDC No. 497\/2021.","breadcrumb":{"@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/21\/anvisa-releases-priority-queues-for-gmp\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/21\/anvisa-releases-priority-queues-for-gmp\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/21\/anvisa-releases-priority-queues-for-gmp\/#primaryimage","url":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2026\/08\/ANVISA-releases-priority-queues-for-GMP-certification-applications.jpg","contentUrl":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2026\/08\/ANVISA-releases-priority-queues-for-GMP-certification-applications.jpg","width":1800,"height":900,"caption":"ANVISA releases priority queues for GMP certification applications"},{"@type":"BreadcrumbList","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/21\/anvisa-releases-priority-queues-for-gmp\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Not\u00edcias","item":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/"},{"@type":"ListItem","position":2,"name":"ANVISA releases priority queues for GMP certification applications"}]},{"@type":"WebSite","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/#website","url":"https:\/\/www.vitapharmaconsulting.com\/en\/","name":"Vita","description":"Regulatory affairs &amp; consulting","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vitapharmaconsulting.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"}]}},"_links":{"self":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/noticias\/1156","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/noticias"}],"about":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/types\/noticias"}],"author":[{"embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/users\/3"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/media\/1157"}],"wp:attachment":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/media?parent=1156"}],"wp:term":[{"taxonomy":"categorias","embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/categorias?post=1156"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}